Related Articles
Age, margin status, high‑risk human papillomavirus and cytology independently predict recurrent high‑grade cervical intraepithelial neoplasia up to 6 years after treatment
Self‑sampling for high‑risk human papillomavirus as a follow‑up alternative after treatment of high‑grade cervical intraepithelial neoplasia
Results of cytology and high‑risk human papillomavirus testing in females with cervical adenocarcinoma in situ
High-risk human papillomavirus E6/E7 mRNA and L1 DNA as markers of residual/recurrent cervical intraepithelial neoplasia
Persistence of HPV after radio-chemotherapy in locally advanced cervical cancer